These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15289839)

  • 21. Ethanol ablation of hepatocellular carcinoma Up to 5.0 cm by using a multipronged injection needle with high-dose strategy.
    Kuang M; Lu MD; Xie XY; Xu HX; Xu ZF; Liu GJ; Yin XY; Huang JF; Lencioni R
    Radiology; 2009 Nov; 253(2):552-61. PubMed ID: 19709992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of nonsurgical treatments for hepatocellular carcinoma in the caudate lobe.
    Shibata T; Maetani Y; Ametani F; Kubo T; Itoh K; Konishi J
    Cardiovasc Intervent Radiol; 2002; 25(3):186-92. PubMed ID: 12058213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma.
    Koda M; Murawaki Y; Mitsuda A; Ohyama K; Horie Y; Suou T; Kawasaki H; Ikawa S
    Cancer; 2000 Feb; 88(3):529-37. PubMed ID: 10649243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CT-guided treatment of ultrasonically invisible hepatocellular carcinoma.
    Sato M; Watanabe Y; Tokui K; Kawachi K; Sugata S; Ikezoe J
    Am J Gastroenterol; 2000 Aug; 95(8):2102-6. PubMed ID: 10950066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination therapy of percutaneous mitoxantrone injection, percutaneous ethanol injection, and transcatheter arterial embolization for intrahepatic hepatocellular carcinoma and adrenal metastasis.
    Kiba T; Numata K; Kitamura T; Morita K; Saito S; Sekihara H
    Hepatogastroenterology; 2001; 48(38):427-31. PubMed ID: 11379324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocellular carcinoma: CT appearance of parenchymal changes after percutaneous ethanol injection therapy.
    Yoshikawa J; Matsui O; Kadoya M; Gabata T; Miyayama S; Takahashi S; Takashima T; Kobayashi K
    Radiology; 1995 Jan; 194(1):107-11. PubMed ID: 7997535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations.
    Wong SN; Lin CJ; Lin CC; Chen WT; Cua IH; Lin SM
    AJR Am J Roentgenol; 2008 Mar; 190(3):W187-95. PubMed ID: 18287411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation.
    Vilana R; Llovet JM; Bianchi L; Sanchez M; Pagés M; Sala M; Gilabert R; Nicolau C; Garcia A; Ayuso C; Bruix J; Bru C;
    J Clin Ultrasound; 2003; 31(3):119-28. PubMed ID: 12594796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Non-real-time computed tomography-guided percutaneous ethanol injection therapy for hepatocellular carcinoma undetectable by ultrasonography].
    Ueda K; Ohkawara T; Minami M; Sawa Y; Morinaga O; Kohli Y; Ohkawara Y
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1254-8. PubMed ID: 9703802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection.
    Ueno H; Okada S; Okusaka T; Ikeda M; Tanaka N; Sakamoto M; Yoshimori M
    Hepatogastroenterology; 2001; 48(41):1430-4. PubMed ID: 11677980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous ethanol injection for hepatocellular carcinoma originating in the caudate lobe.
    Shibata T; Kubo S; Tabuchi T; Maetani Y; Ametani F; Itoh K; Konishi J
    Hepatogastroenterology; 2000; 47(33):824-7. PubMed ID: 10919039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients.
    Dong B; Liang P; Yu X; Su L; Yu D; Cheng Z; Zhang J
    AJR Am J Roentgenol; 2003 Jun; 180(6):1547-55. PubMed ID: 12760916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence.
    Horigome H; Nomura T; Saso K; Itoh M
    Am J Gastroenterol; 1999 Jul; 94(7):1914-7. PubMed ID: 10406259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbon dioxide-enhanced sonographically guided percutaneous ethanol injection: treatment of patients with viable and recurrent hepatocellular carcinoma.
    Chen RC; Liao LY; Wang CS; Chen WT; Wang CK; Li YH; Tu HY; Chen PH
    AJR Am J Roentgenol; 2003 Dec; 181(6):1647-52. PubMed ID: 14627590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of nodular hepatocellular carcinoma larger than 3 cm with ultrasound-guided percutaneous acetic acid injection.
    Ohnishi K; Yoshioka H; Ito S; Fujiwara K
    Hepatology; 1996 Dec; 24(6):1379-85. PubMed ID: 8938165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small hepatocellular carcinoma: safety and efficacy of single high-dose percutaneous acetic acid injection for treatment.
    Liang HL; Yang CF; Pan HB; Lai KH; Cheng JS; Lo GH; Chen CK; Lai PH
    Radiology; 2000 Mar; 214(3):769-74. PubMed ID: 10715044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous microwave coagulation therapy for unresectable hepatocellular carcinoma.
    Ohmoto K; Miyake I; Tsuduki M; Shibata N; Takesue M; Kunieda T; Ohno S; Kuboki M; Yamamoto S
    Hepatogastroenterology; 1999; 46(29):2894-900. PubMed ID: 10576369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CT-guided transthoracic percutaneous ethanol injection for hepatocellular carcinoma not detectable with US.
    Shibata T; Iimuro Y; Yamamoto Y; Ikai I; Itoh K; Maetani Y; Ametani F; Kubo T; Konishi J
    Radiology; 2002 Apr; 223(1):115-20. PubMed ID: 11930055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Percutaneous ethanol and lipiodol injection therapy for hepatocellular carcinoma.
    Kurokohchi K; Masaki T; Miyauchi Y; Funaki T; Yoneyama H; Miyoshi H; Yoshida S; Himoto T; Morishita A; Uchida N; Watanabe S; Kuriyama S
    Int J Oncol; 2004 Feb; 24(2):381-7. PubMed ID: 14719115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
    De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
    Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.